Skip to main content
Zeil Rosenberg, MD, Infectious Disease, Chatham, NJ

ZeilRosenbergMDMPH, FAAP

Infectious Disease • Chatham, NJ

Executive Vice President, Tonix Pharmaceuticals

Join to view full profile

Dr. Rosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rosenberg's full profile

Already have an account?

  • Office

    Main Street
    Chatham, NJ 07928
    Phone+1 212-980-9155

Summary

  • Dr. Rosenberg is Executive Vice President, Medical at Tonix Pharmaceuticals. He is responsible for leading Tonix’s clinical development efforts for vaccines and antivirals and oversees the clinical development of Tonix’s vaccine for smallpox and monkeypox, TNX-801, and the next generation vaccine platform developed for COVID-19 and other infectious diseases, TNX-1800 . He also heads Medical Affairs for the commercial CNS drugs Tosymra and Zembrace.

    Previous to this he was at PPD as Executive Medical Director, Biotech, at PPD/AES as Therapeutic Area Head for Vaccines at PPD AES and was Worldwide Medical Director, Immunization at Becton Dickinson (BD).

Education & Training

  • Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public HealthFellowship, Public Health and General Preventive Medicine, 1987 - 1988
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Public Health and General Preventive Medicine, 1984 - 1986
  • Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)
    Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)Internship, Internal Medicine, 1983 - 1984
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1984 - 2027
  • NJ State Medical License
    NJ State Medical License 2001 - 2025
  • DC State Medical License
    DC State Medical License 1986 - 1997
  • American Board of Preventive Medicine Public Health & General Preventive Medicine
  • Specialty Fellow, American Academy PediatricsFAAP

Awards, Honors, & Recognition

  • Child Survival Fellow Johns Hopkins School of Public Health, 1986
  • Science, Engineering and Diplomacy Fellow AAAS, 1985
  • International Fellow School of International and Public Affairs, Columbia, 1985

Publications & Presentations

PubMed

Press Mentions

  • British Doctors Are on Alert over the Spread of a Deadly New Variant of the Mpoxvirus – After the WHO Declared a Global Health Emergency Following the Outbreak in Africa
    British Doctors Are on Alert over the Spread of a Deadly New Variant of the Mpoxvirus – After the WHO Declared a Global Health Emergency Following the Outbreak in AfricaAugust 16th, 2024
  • Admera Health Receives CLIA Approval for Its Breakthrough Liquid Biopsy Testing Platform
    Admera Health Receives CLIA Approval for Its Breakthrough Liquid Biopsy Testing PlatformFebruary 9th, 2016
  • Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-801 as a Potential Vaccine to Prevent Mpox and Smallpox
    Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-801 as a Potential Vaccine to Prevent Mpox and SmallpoxAugust 25th, 2023

Dr. Zeil Rosenberg, Dr. Zeil Rosenberg, MD, Dr. Z Rosenberg